We are experts at solving some of the most complex actuarial challenges for our clients in the financial services sector.
Eckler’s GroupNews monthly newsletter provides commentary on the issues affecting Canadian group benefit plans. In this edition: Nova Scotia announces move to biosimilar drugs for ...
